Position: Consultant Cardiologist
Location: Cambridge, UK
Andrew Grace is Consultant Cardiologist at Royal Papworth Hospital in Cambridge. He has a consistently high volume interventional practice focused on the cardiac rhythm having trained in cardiology in both London and Cambridge. He is also Research Group Head in the Department of Biochemistry, University of Cambridge. He completed post-doctoral studies as a Fulbright Scholar/British Heart Foundation Fellow in the Department of Medicine, University of California, San Diego and was then BHF Senior Research Fellow in Cambridge.
He has spent over 20 years addressing the impact of genetic variation on the cardiac rhythm. He is a recognized innovator having a particular interest in ‘disruptive’ technologies designed to improve patient care that have included devices, diagnostics and drugs. Some of his work has already changed practice making some of the ‘most important contributions’ to the development and implementation of subcutaneous defibrillators. His clinical research focus is currently on both high-resolution charge density mapping of cardiac activation and risk prediction of ventricular fibrillation.
He has published extensively and given many invited lectures that include hotline presentations of clinical trial data and highlighted late-breaking basic science. He is an Editor/Editorial Board member of several journals and a member of numerous Boards including the BHF Translational Awards Committee, UK Government Commission on Human Medicines, European Medicines Agency, European Society of Cardiology SVT Guidelines Committee, Boston Scientific Inc. Advisory Board and is the International Ambassador for the American Heart Association Leadership Committee on Genomic and Precision Medicine.